Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,051 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details
Completed

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

NCT03886831

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Anemia, +39 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSF Precision Cancer Medicine Building San Francisco, California, United States
  • Christiana Care Health Services, Christiana Hospital Newark, Delaware, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
View all 23 locations
View Trial Details
Completed

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

NCT03775850

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +35 more
Locations
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Tennessee Oncology, PLLC Chattanooga, Tennessee, United States
View Trial Details
Completed

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

NCT03428217

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
View all 133 locations
View Trial Details

Related conditions